Scholarlink

<p><i>Desmodium gangeticum</i> (“Salparni”) is a pharmacologically significant Ayurvedic plant rich in bioactive secondary metabolites. However, industrial up-scaling is hindered by an over reliance on wild populations and unoptimized cultivation workflows, while existing literature details its phytochemistry and pharmacology, a comprehensive framework integrating traditional applications with modern metabolic and culture optimization is lacking. This review addresses this gap by evaluating phytochemical; diversity, therapeutic applications, and advanced biotechnological cultivation strategies specifically in-vitro propagation, hydroponics, and elicitor-mediated secondary metabolite enhancement. Furthermore, the molecular and genetic mechanisms regulating gene expression and metabolic pathways that govern biomass and bioactive compound accumulation have been been emphasized. By providing actionable insights into scalable standardized production, the review outlines the development of reliable agro-industrial value chains to maximize the commercial and pharmacological potential of <i>D. gangeticum.</i></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Enhancing the commercial value of Desmodium gangeticum (L.) DC.: integration of traditional and biotechnological approaches

  • 期刊论文

  • 发表日期：

    2026年7月6日

查看全文
  • Mansi Singh Bisen,
  • Supriya Tiwari,
  • Shashi Bhushan Agrawal,
  • N. Shiddamallayya,
  • Jagdish Chandra Arya,
  • Sugriv Kumar Gaur,
  • Shashi Pandey-Rai

摘要

Desmodium gangeticum (“Salparni”) is a pharmacologically significant Ayurvedic plant rich in bioactive secondary metabolites. However, industrial up-scaling is hindered by an over reliance on wild populations and unoptimized cultivation workflows, while existing literature details its phytochemistry and pharmacology, a comprehensive framework integrating traditional applications with modern metabolic and culture optimization is lacking. This review addresses this gap by evaluating phytochemical; diversity, therapeutic applications, and advanced biotechnological cultivation strategies specifically in-vitro propagation, hydroponics, and elicitor-mediated secondary metabolite enhancement. Furthermore, the molecular and genetic mechanisms regulating gene expression and metabolic pathways that govern biomass and bioactive compound accumulation have been been emphasized. By providing actionable insights into scalable standardized production, the review outlines the development of reliable agro-industrial value chains to maximize the commercial and pharmacological potential of D. gangeticum.